Loading ...
the major factorsleadingto the non adherence to the medication
factors and barriersleadingto medication non - adherence
important factorscontributingto medication non - adherence
eight factorscontributeto medication non - adherence
Several factorsleadto medication non - adherence
numerous factorscan contributeto medication non - adherence
The causes and factorscontributeto medication non - adherence
key factorscontributingto medication non - adherence
which of the following factorsto contributeto medication non - adherence
many factorscontributeto medication non - adherence
the combination of factorscausemedication non - adherence
the contextual factorscontributeto medication non - adherence
The three main factorsmay contributeto non - adherence to medication
factors ... multiple domainswere contributingto medication non - adherence
six main factorscontributeto medication non adherence
key patient and healthcare provider factorscontributeto medication non - adherence
the physician , the healthcare system , and economic and social factors(passive) is influenced byNon - adherence to medication
clinical or treatment and illness - related , and health system factorsinfluencedpsychotropic medication non - adherence
multiple factors such as : Fear of potential side - effects and interactions with medications they currently use(passive) is caused byMedication non - adherence
the total costs of unnecessary medical expendituresresultingfrom medication non - adherence
various factors such as patients ’ individual behavior , social or family support , clinical or illness and treatment - related , and overall health care system - related factors(passive) is influenced byMedication non - adherence
the high cost of prescriptions ... the primary factorleadsto medication non - adherence
a major factorcontributingtowards the medication non - adherence
the most important factorcontributingto medication non - adherence
a prominent factorinfluencingmedication non - adherence
one factorcontributingto medication non - adherence
Cost ... a factorcan causemedication non - adherence
In the UAE , proper guidance on use of these medications is often missingleadsto non - adherence to medications
forgetting and delays(passive) caused byMedication non - adherence
organized reports ... various reasonsleadto medication non - adherence
the plethora of issuescan leadto ' medication non - adherence
the sticker shock and delayscan leadto medication non - adherence
Barrier # 5 - Side Effects Experiencing negative side effects , or even the fear of perceived side effectsmay leadto medication non - adherence
generic medications and the issue of potencycould contributeto medication non - adherence
an important role in optimizing medication adherence , therapeutic outcomes ... the issuescausemedication non - adherence
Poor health outcomes and increased healthcare costscan resultfrom medication non - adherence
how mental health issues , particularly depressioncontributedto non - adherence to medications
Fear of side effectscan contribute greatlyto medication non - adherence ( noncompliance
higher out - of - pocket costs and pharmacy closurescontributeto medication non - adherence
treatment instructionsleadingup to medication non - adherence
30 - 50 % of treatment failures and 125,000 deaths annuallycauses30 - 50 % of treatment failures and 125,000 deaths annually
nearly 125,000 deaths in a yearcausesnearly 125,000 deaths in a year
30 - 50 % of chronic disease treatment failures and 125,000 deaths per year in the United Statescauses30 - 50 % of chronic disease treatment failures and 125,000 deaths per year in the United States
to serious consequencescan leadto serious consequences
30 - 50 percent of treatment failures and 125,000 deaths annuallycauses30 - 50 percent of treatment failures and 125,000 deaths annually
to poor clinical outcomes for South Asian patients with diabetes and CVDmay leadto poor clinical outcomes for South Asian patients with diabetes and CVD
to poor clinical outcomes for South Asian patients\ud with diabetes and CVDmay leadto poor clinical outcomes for South Asian patients\ud with diabetes and CVD
nearly 125,000 deaths per yearcausesnearly 125,000 deaths per year
to the increased morbidity and mortality observed in patients with PTSDmay contributeto the increased morbidity and mortality observed in patients with PTSD
125,000 deaths annually and accounts for 10 % to 25 % of hospital and nursing home admissionscauses125,000 deaths annually and accounts for 10 % to 25 % of hospital and nursing home admissions
in more than 125,000 deaths annually in the U.S. and added costs between $ 105 billion and $ 290 billionresultedin more than 125,000 deaths annually in the U.S. and added costs between $ 105 billion and $ 290 billion
in more than 125,000 deaths annually nationwide and added costs between $ 105 billion to $ 290 billionresultedin more than 125,000 deaths annually nationwide and added costs between $ 105 billion to $ 290 billion
to more hospitalization of SLE patientsleadsto more hospitalization of SLE patients
to worsening health conditions , hospitalizations and deathcan leadto worsening health conditions , hospitalizations and death
approximately 125,000 deaths and 10 % of hospitalizations annuallycausesapproximately 125,000 deaths and 10 % of hospitalizations annually
nearly 125,000 deaths and 10 percent of hospitalizationsleadsnearly 125,000 deaths and 10 percent of hospitalizations
to increased morbidity , mortality , and costs to the healthcare system due to elevated risk of stent thrombosis , myocardial infarction or deathmay leadto increased morbidity , mortality , and costs to the healthcare system due to elevated risk of stent thrombosis , myocardial infarction or death
to 125,000 deaths and $ 90 billion in additional hospitalization and proceduresleadsto 125,000 deaths and $ 90 billion in additional hospitalization and procedures
to worsening disease progressionwill leadto worsening disease progression
to $ 100-$290 billion in direct and indirect costs annually.3leadsto $ 100-$290 billion in direct and indirect costs annually.3
to poor health outcomes for patients , which can ultimately lead to additional costs for employerscan leadto poor health outcomes for patients , which can ultimately lead to additional costs for employers
in illness relapse , hospitalization , poorer outcomes and increased financial burden for patients and societycan resultin illness relapse , hospitalization , poorer outcomes and increased financial burden for patients and society
to a U.S. deathleadsto a U.S. death
125,000 deaths and 10 % of hospitalizations which costs approximately US$ 528 Billioncauses125,000 deaths and 10 % of hospitalizations which costs approximately US$ 528 Billion
in an additional $ 100 billion in annual health care costs and $ 50 billion in indirect productivity lossescan resultin an additional $ 100 billion in annual health care costs and $ 50 billion in indirect productivity losses
to serious health consequences and higher medical costscan leadto serious health consequences and higher medical costs
severe health complications and hospitalizationscould causesevere health complications and hospitalizations
Clinicians 's kidney transplant to failcausedClinicians 's kidney transplant to fail
to complications that ultimately make patients more expensive to treatcan leadto complications that ultimately make patients more expensive to treat
to another problem where the patients could be admitted to the hospitalhas also ledto another problem where the patients could be admitted to the hospital
in an additional $ 100 billion in annual health care costs Osterberg , New England Journal of Medicine , 2005 and $ 50 billion Peterson , Amercan resultin an additional $ 100 billion in annual health care costs Osterberg , New England Journal of Medicine , 2005 and $ 50 billion Peterson , Amer
125,000 deaths yearly and can be accounted for 10 % to 25 % of reported nursing home and hospital admissions in the United States alonecauses125,000 deaths yearly and can be accounted for 10 % to 25 % of reported nursing home and hospital admissions in the United States alone
to exacerbation of their illnesscan leadto exacerbation of their illness
problems for patients , healthcare providers , payers and pharma companiescausesproblems for patients , healthcare providers , payers and pharma companies
from patients ' inability to read and comprehend medication labelsresultingfrom patients ' inability to read and comprehend medication labels
in serious health consequences , including delayed recovery , disease relapse , hospitalization and even death[3can resultin serious health consequences , including delayed recovery , disease relapse , hospitalization and even death[3
dangerous problems in patients with more severe medical conditions , especially in diabetics and those with heart diseasecan causedangerous problems in patients with more severe medical conditions , especially in diabetics and those with heart disease
to suboptimal outcomes and has been seen in almost half of graft losses.2 , 10 , 11 Non - adherence is associated with decreased graft function ... increased risk of kidney loss , and premature death.12Immunosuppressive treatment regimens are complex and require ongoing self - managementleadsto suboptimal outcomes and has been seen in almost half of graft losses.2 , 10 , 11 Non - adherence is associated with decreased graft function ... increased risk of kidney loss , and premature death.12Immunosuppressive treatment regimens are complex and require ongoing self - management
in a worsening of a patient ’s condition and , potentially , more frequent hospitalization and/or emergency department visitscould resultin a worsening of a patient ’s condition and , potentially , more frequent hospitalization and/or emergency department visits
to 125,000 preventable deaths and more than $ 300 billion in avoidable healthcare costs in the U.S.leadsto 125,000 preventable deaths and more than $ 300 billion in avoidable healthcare costs in the U.S.